Healthcare Innovation in the 21st Century:
HHS’ Dynamic Role in the Biomedical and Device Development Process


Co-Hosted By:

Join a panel discussion with Deputy Secretary of the HHS Tevi D. Troy, Ph.D., and senior officials from the National Institutes of Health (NIH), the Food and Drug Administration (FDA), the Centers for Medicare & Medicaid Services (CMS), and the Agency for Healthcare Research and Quality (AHRQ) to highlight the work taking place in and between their respective agencies to facilitate the development of innovative medical technologies.

Wednesday, December 10, 2008
Byers Auditorium
Genentech Hall
UCSF Mission Bay
600 16th St.
San Francisco, CA
9:00 – 11:00 a.m.

**Free of charge for all attendees**

To register, please email Kathryn Bailey at or
call 650-871-7101x217 by Wednesday, December 3

For more information please visit


Welcoming Remarks
Regis B. Kelly, Ph.D.
Director, The California Institute for Quantitative Biosciences

Opening Remarks and Introduction of Deputy Secretary Tevi Troy
Matthew M. Gardner
President and CEO, BayBio

Promoting and Facilitating Innovation: HHS’ Dynamic Role
Tevi D. Troy, Ph.D.
Deputy Secretary, U.S. Department of Health and Human Services

NIH: Investing in Innovation
Alan Guttmacher, M.D.
Acting Director, National Human Genome Research Institute National Institutes of Health

FDA: Paving the Pathway for Innovation
Frank Torti, M.D., M.P.H.
Principal Deputy Commissioner and first Chief Scientist Food and Drug Administration

CMS: Funding the Innovators of Today and Tomorrow
Herb Kuhn
Deputy Administrator and Acting Director, Center for Medicaid and State OperationsCenters for Medicare and Medicaid Services (Tentative)

AHRQ: Helping Organizations Innovate and Adopt New Ideas
Jean Slutsky, M.S.P.H.
Director, Center for Outcomes Evidence (Tentative

This email was sent by: %%Member_Busname%%
%%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

Unsubscribe from this list.